Midostaurin abrogates CD33-directed UniCAR and CD33-CD3 bispecific antibody therapy in acute myeloid leukaemia

Fasslrinner, F; Arndt, C; Koristka, S; Feldmann, A; Altmann, H; von Bonin, M; Schmitz, M; Bornhauser, M; Bachmann, M

Bachmann, M (reprint author), HZDR, Dept Radioimmunol, Inst Radiopharmaceut Canc Res, Bautzner Landstr 400, D-01328 Dresden, Germany.

BRITISH JOURNAL OF HAEMATOLOGY, 2019; 186 (5): 735

Abstract

Combinatory therapeutic approaches of different targeted therapies in acute myeloid leukaemia are currently under preclinical/early clinical investiga......

Full Text Link